Ranked in 1 Practice Areas
U

Up and Coming

Food & Beverages: Regulatory & Litigation

USA - Nationwide

1 Years Ranked

About

Provided by Xin Tao

USA

Practice Areas

A former research scientist, Xin brings a deep understanding of the complex scientific issues that relate to the US legal compliance and government enforcement issues, enabling him to help clients with all phases of product development, manufacturing, and marketing. As the science and technology continues to evolve, Xin supports our clients to constantly innovate and push the boundaries of what's possible in the world of science.

Xin's practice focuses on advising high-growth companies and investors in food and beverage, healthcare, and e-commerce industries globally. As part of the Firm's US Government Enforcement Practice, he has represented many global companies during high-stakes US government investigations (including actions initiated by the US Congress, US Department of Justice (DOJ), and US Food and Drug Administration (FDA)) around the world. Xin also has a strong track record in US consumer product recall matters, and with a deep understanding of the intricacies involved in navigating the complex and interrelated legal and scientific issues, Xin can creatively and effectively represent companies in these bet-the-company cases.

As a seasoned US government regulatory and enforcement counsel, Xin works closely with global companies with novel pharmaceutical, medical device, food, and cosmetic applications that require the US government's pre-market approval or clearance and FDA Current Good Manufacturing Practices (cGMP) compliance.

Publications

• Co-author. "Key Legal Trends for Healthcare And Life Sciences In 2024," Law360, 8 January 2024

• Co-author. "Staying ahead of FDA drug cGMP enforcement," JD Supra, 03 February 2023

• Co-author. "Assuring the Food Safety of Crops Developed through Breeding," ACS Agricultural Science & Technology, 2022

• Co-author, "FDA completes first pre-market consultation for human food made with animal cell culture technology," JD Supra, 21 November 2022

• Co-author, "FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products," JD Supra, 18 May 2022

• Co-author, "What To Do As PFAS Food Packaging Phaseouts Approach," Law360, 21 January 2022

Expert in these Jurisdictions

USA

Languages Spoken

English

Mandarin

Education

Georgetown University Law Center

JD

2012

Texas A&M University

MS

2009

Shanghai Jiao Tong University

BS

2006

Discover other Lawyers at
Baker McKenzie

Provided by Chambers
Filter by
Band

California

Labor & Employment

Robin Samuel
5
Robin Samuel
5
Band 5
Litigation: Securities

Perrie M Weiner
3
Perrie M Weiner
3
Band 3
Litigation: White-Collar Crime & Government Investigations

Jessica Nall
3
Jessica Nall
3
Band 3

California: Los Angeles & Surrounds

Employee Benefits & Executive Compensation

Matthew Schonholz
3
Matthew Schonholz
3
Band 3

California: Northern

Tax

Gary D Sprague
1
Gary D Sprague
1
Band 1
Stewart R Lipeles
3
Stewart R Lipeles
3
Band 3
4
Scott H Frewing
4
Band 4

California: San Francisco, Silicon Valley & Surro

Corporate/M&A

Leif King
4
Leif King
4
Band 4
Employee Benefits & Executive Compensation

Barbara Klementz
2
Barbara Klementz
2
Band 2
Denise M Glagau
3
Denise M Glagau
3
Band 3
Sinead M Kelly
3
Sinead M Kelly
3
Band 3

California: Southern

Tax

David B. Goldman
3
David B. Goldman
3
Band 3

District of Columbia

Immigration

Matthew Gorman
Matthew Gorman
Associates to watch
Intellectual Property: Patent Prosecution

Richard Wells
2
Richard Wells
2
Band 2
Tax

3
A Duane Webber
3
Band 3
5
Alexandra Minkovich
5
Band 5
5
Christine Sloan
5
Band 5
Salim Rahim
5
Salim Rahim
5
Band 5

Florida

Bankruptcy Litigation

1
Mark D Bloom
1
Band 1
Litigation: General Commercial

Daniela Fonseca Puggina
4
Daniela Fonseca Puggina
4
Band 4
20 of 96 results